Q1 2018 Holdings
Filed 2018-05-15 | 75 holdings | $31.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $8.0M | 389,145 | 25.7% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $5.8M | 610,738 | 18.7% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $5.2M | 79,245 | 16.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.7M | 58,130 | 15.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.6M | 974,652 | 15.0% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.3M | 247,859 | 4.0% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $1.2M | 7,330 | 4.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $116.0K | 7,500 | 0.4% |
| Loxo Oncology Inc | COM | 548862101 | $20.9K | 181,537 | 0.1% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $15.1K | 94,000 | 0.0% |
| Stereotaxis Inc(STXS) | COM | 85916J409 | $9.1K | 13,680,554 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $8.1K | 88,691 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $7.6K | 306,119 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $7.2K | 132,770 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.6K | 75,000 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $5.0K | 396,013 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $5.0K | 126,742 | 0.0% |
| Luminex Corp | COM | 55027E102 | $4.8K | 227,500 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $4.5K | 54,508 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $4.2K | 323,843 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $4.1K | 280,900 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $4.0K | $4,000,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $4.0K | 39,609 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $3.8K | 94,264 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $3.5K | 998,000 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $3.2K | 868,272 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $3.2K | 901,933 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $2.8K | 32,484 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $2.8K | 26,100 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.4K | 127,000 | 0.0% |
| Scynexis Inc | COM | 811292101 | $2.2K | 1,636,900 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.2K | 69,500 | 0.0% |
| Protalix Biotherapeutics Inc | NOTE 4.500% 9/1 | 74365AAB7 | $2.1K | $2,500,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $2.1K | 83,105 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.9K | 377,695 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $1.8K | 44,400 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $1.7K | 335,500 | 0.0% |
| Insulet Corp | NOTE 1.375% | 45784PAG6 | $1.7K | $1,500,000 | 0.0% |
| Leap Therpeutics Inc | COM | 52187K101 | $1.7K | 200,000 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $1.6K | 421,000 | 0.0% |
| Clementia Pharmaceuticals in | COM | 185575107 | $1.6K | 105,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $1.5K | 107,928 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $1.4K | 484,984 | 0.0% |
| Natus Medical Inc | COM | 639050103 | $1.3K | 37,900 | 0.0% |
| Proteostasis Therapeutics in | COM | 74373B109 | $1.3K | 267,100 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $1.3K | 15,000 | 0.0% |
| Johnson and Johnson(JNJ) | COM | 478160104 | $1.2K | 9,400 | 0.0% |
| Cogentix Medical Inc | COM | 19243A104 | $1.2K | 310,382 | 0.0% |
| Dermira Inc | NOTE 3.000% 5/1 | 24983LAA2 | $1.2K | $1,500,000 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $1.2K | 697,000 | 0.0% |